Sinovial HL represents a groundbreaking hybrid hyaluronic acid (HA) formulation comprising a blend of high and low molecular weight HA complexes. These complexes, interconnected via hydrogen bonds, are crafted using the patented NAHYCO technology, employing heat treatment to merge molecular weights without any chemical additives. This unique process ensures that the product emulates the natural synovial fluid present in the body.

Clinical Applications:

Sinovial HL is indicated for the treatment of osteoarthritis and associated symptoms like pain and restricted mobility due to degenerative conditions (arthrosis), post-traumatic issues, and tendinopathies affecting joint functionality. It is efficacious for both acute and chronic tendinopathies, facilitating tendon repair and rehabilitation. By replenishing synovial fluid, it reinstates the physiological and rheological attributes of joints and tendons. Sinovial HL 64 2ml is specifically formulated for larger joints such as the hip, while Sinovial HL 32 caters to smaller joints.

Within the joint, Sinovial HL alleviates pain and enhances mobility devoid of systemic repercussions. It functions by enhancing lubrication and viscoelastic properties within tendon sheaths, augmenting tendon glide, and supporting natural healing and regeneration processes, thereby mitigating adhesion formation post-surgery.

Composition:

Each product contains 32 mg of a blend of high and low molecular weight HA.

Advantages of High HA Concentrations with Low Viscosities:

Developed by IBSA using NAHYCO Hybrid Technology, this advanced thermal process avoids chemical additives and fosters weak hydrogen bonds between long-chain (high molecular weight) and short-chain (low molecular weight) HA. This yields stabilized hybrid complexes with sustained high HA concentrations at low viscosities, ensuring effortless extrusion without compromising efficacy. The amalgamation of diverse molecular weights imparts Sinovial HL with properties mirroring those of natural joint synovia.

Storage:

Store at room temperature, below 25°C, and away from heat sources. Avoid freezing.

Expiry Date:

The product maintains a shelf life of 36 months provided the packaging remains intact.

Warnings:

The contents of the ampoule syringes are sterile, with the syringe and needle sealed within a blister pack. The external surface of the syringe is non-sterile. Do not utilize if the packaging is damaged or past the expiry date. Apply exclusively to healthy skin and inject solely within the joint cavity. Refrain from use in cases of significant joint effusion, joint infection, severe inflammation, or skin disorders at the injection site. Sinovial HL is intended for single use to mitigate infection risks and should neither be resterilized nor mixed with disinfectants like quaternary ammonium salts or chlorhexidine, as precipitation may occur. Post-use, promptly dispose of and keep out of reach of children. Patients should abstain from strenuous activities for several days following injection. The presence of air bubbles does not affect the product’s efficacy.

The product is intended for professional use.